Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
about
Olanzapine versus other atypical antipsychotics for schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaZiprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.A review of executive function deficits and pharmacological management in children and adolescents.A review of pharmacologic strategies for switching to atypical antipsychoticsSymptom domains of schizophrenia: the role of atypical antipsychotic agents.Methods for treating cognitive deficits in schizophrenia.Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional studySocial functioning as an outcome measure in schizophrenia studies.Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.Cognitive deficits and functional outcome in schizophrenia.Refining the latent structure of neuropsychological performance in schizophrenia.The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
P2860
Q24236545-76693824-E3B0-4A90-8481-FBEC6DD01CC8Q24240260-3069C53C-755D-449C-9589-BF42A8EC9D96Q30984472-1070116E-1457-415F-ACCE-789FC96B117DQ33223628-C96BCFCF-7728-466F-B816-EA06AC323608Q33235110-FB2B7457-D229-4204-881D-A922F2E0F623Q33605308-F46E408C-C2F8-4D56-8AB6-EFEEE25C4A5AQ34293012-4500ABCA-4BDD-43DC-8452-D14DF896E9D9Q36199687-11CC1B42-7DC2-4C0D-9AE4-8C531EF29D04Q36626242-A2BA6369-D327-4E72-AD0A-8E57C8EDEAC0Q36752922-C4242DFE-36B4-44A4-8A1A-CF929DE84C73Q36925204-5A0938FD-A490-4330-A135-E1FFA8546F09Q36973846-478119C3-9541-46E0-A1FA-18D76F328FD6Q37075965-56E43932-1086-4A1B-97B6-C776FE5B3658Q37106946-70A82422-C150-4617-8B05-09AC93CC5870Q37166100-58B4E496-E84E-4D78-BD20-5D57621EEF61Q44600736-0715A85F-8ED5-4D94-B83C-B41FFF18093CQ44883674-9B5AA594-4ED5-4E6B-BFD6-6028AF14C65EQ45172279-BF1E074C-7C77-4625-A264-69E191B57C7C
P2860
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Randomized, controlled, double ...... a or schizoaffective disorder.
@en
Randomized, controlled, double ...... a or schizoaffective disorder.
@nl
type
label
Randomized, controlled, double ...... a or schizoaffective disorder.
@en
Randomized, controlled, double ...... a or schizoaffective disorder.
@nl
prefLabel
Randomized, controlled, double ...... a or schizoaffective disorder.
@en
Randomized, controlled, double ...... a or schizoaffective disorder.
@nl
P1433
P1476
Randomized, controlled, double ...... a or schizoaffective disorder.
@en
P2093
Cynthia O Siu
Steven Romano
P2888
P304
P356
10.1007/S00213-003-1652-2
P577
2003-11-13T00:00:00Z